Skip to main content
. 2018 Sep 23;194(2):220–230. doi: 10.1111/cei.13161

Figure 2.

Figure 2

Cyclin‐dependent kinase inhibitor 1A (CDKN1A) expression in rheumatoid arthritis (RA) tissues and human fibroblast‐like synoviocytes (HFLS). (a) CDKN1A mRNA was decreased significantly in the RA group compared with the healthy control (HC) group. (b) The level of CDKN1A was inhibited in the HFLS‐RA group. (c) Compared with the HFLS group, the CDKN1A protein level was also inhibited in the HFLS‐RA group. *P < 0·05; **P < 0·01.